HomeTLSI • NASDAQ
TriSalus Life Sciences Inc
add
$4.92
2.50%
After Hours:(0.00%)0.00
$4.92
Closed: Sep 18, 4:01:46 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 11.21M | 52.27% |
Operating expense | 16.74M | 14.47% |
Net income | -8.29M | -91.32% |
Net profit margin | -73.91 | -25.63% |
Earnings per share | -0.23 | — |
EBITDA | -7.17M | 10.19% |
Effective tax rate | 0.04% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 26.49M | 60.73% |
Total assets | 41.32M | 27.40% |
Total liabilities | 60.74M | 7.35% |
Total equity | -19.42M | — |
Shares outstanding | 49.87M | — |
Price to book | -9.41 | — |
Return on assets | -52.41% | — |
Return on capital | -282.33% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -8.29M | -91.32% |
Cash from operations | -7.32M | 45.46% |
Cash from investing | 93.00K | 255.00% |
Cash from financing | 20.72M | -20.30% |
Net change in cash | 13.49M | 7.83% |
Free cash flow | -6.89M | 30.08% |
Previous close
$4.80
Day range
$4.71 - $5.04
Year range
$3.42 - $5.88
Market cap
245.35M USD
Avg Volume
111.16K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2009
Headquarters
Website
Employees
110
